✕
CLOSE
Glytec is the insulin management software company for healthcare providers focused on improving the quality and cost of care. Its FDA-cleared titration software and proprietary algorithms power the only solution capable of delivering personalized diabetes treatment recommendations across the continuum of care, from hospital to home.
With ongoing support from its team of doctors, nurses and technologists headquartered outside of Boston, Glytec improves outcomes and controls costs for the large population of patients requiring insulin treatment – including those with and without a diagnosis of diabetes.
Founded: 2006
Industry: Insulin Management
Size: +100 employees
Headquarters: Boston, MA
Website: www.glytec.com
Related Articles
Glytec Secures $36 Million Growth Investment to Accelerate AI-Powered Diabetes Technology Platform Innovation
BOSTON, MA – June 17, 2025 – Glytec, the leading provider of an AI-powered technology platform for diabetes and related conditions, today announced it has closed a $36 million growth investment led by Savitr Capital and Hayfin Capital Management. This significant...
MUSC to leverage Glytec software to enhance clinical outcomes, quality, safety
New collaboration to have broad impact on diabetes, insulin management for leading academic health system in South Carolina BOSTON, MA – May 20, 2025 – Glytec, the Software-as-a-Service (SaaS) technology leader and pioneer in diabetes and insulin management, is proud...
Glytec Software Wins “Best Computerized Decision Support Solution” in 2025 MedTech Breakthrough Awards Program
Prestigious International Annual Awards Program Recognizes Standout Digital Health & Medical Technology Products and Companies BOSTON, MA – May 8, 2025 – Glytec, the Software-as-a-Service (SaaS) technology leader and pioneer in diabetes and insulin management,...
Glytec Advances Market Leadership in Critical Time for the Hospital Industry
Patient outcomes, client growth, and industry cost savings align to new, CMS requirements for hospitals. BOSTON, Mass. [February 13, 2025] – Glytec, the pioneer in cloud-based diabetes and insulin management Software-as-a-Service (SaaS) technology completed a record...
Glytec partners with TidalHealth to improve hospital-based clinical outcomes and insulin management
BOSTON, Mass. [January 14, 2025] – Glytec, the pioneer in cloud-based diabetes and insulin management Software-as-a-Service (SaaS) technology, is proud to announce a new strategic partnership with TidalHealth, an integrated health system based in Salisbury, Maryland....
Glytec Joins Leapfrog’s Partner Advisory Committee to Advance Patient Safety and Improve Inpatient Diabetes Management
Collaboration to Drive Healthcare Innovation Amidst Industry Urgency BOSTON, Mass. (October 31, 2024) – Glytec, the leading provider of diabetes and insulin management software as a service (SaaS), is excited to announce its collaboration with The Leapfrog Group...